Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
A new biomarker that predicts ventricular arrhythmia in patients with ischemic dilated cardiomyopathy: Galectin-3
Onur Erdogan; Ekrem Karaayvaz; Tugba Erdogan; Cafer Panc; Remzi Sar¿kaya; Aytac Oncul; Ahmet Kaya Bilge;
Rev Port Cardiol. 2021;40:829-35
Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping
Mário Oliveira; Pedro Cunha; Bruno Valente; Guilherme Portugal; Ana Lousinha; Mariana Pereira; Manuel Braz; Ana Delgado; Rui C. Ferreira;
Rev Port Cardiol. 2021;40:865-73
Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test
Pedro von Hafe; Bebiana Faria; Geraldo Dias; Filipa Cardoso; Maria José Alves; Assunção Alves; Bernardete Rodrigues; Sílvia Ribeiro; Víctor Sanfins; António Lourenço;
Rev Port Cardiol. 2021;40:33-8